RT @gasingiltv: #GI_Cancer #ESMO22 #CDH17 is an attractive target for GI cancer. Some companies are in phase 1 clinical trials with #BsAb.…
4,462 followers
1,270 followers
#GI_Cancer #ESMO22 #CDH17 is an attractive target for GI cancer. Some companies are in phase 1 clinical trials with #BsAb. We will see the initial data of B1 905711 (CDH17×#TRAILR2) in ESMO22. ➡️https://t.co/fEMHwaxtR2
1,511 followers
RT @candacewslei1: Selective tumor cell apoptosis and tumor regression in CDH17-positive colorectal cancer models using BI 905711, a novel…
1,511 followers
RT @MCT_AACR: BI 905711, a bispecific antibody targeting TRAILR2 and CDH17, has potent and selective #AntitumorActivity in CDH17-positive #…